[微笑] 

获FDA批准治疗精神分裂症药物,药企ITCI盘前股价翻倍

12月23日讯,美国食品药品监督管理局(FDA)周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta,受此影响,该公司股价盘前飙
获FDA批准治疗精神分裂症药物,药企ITCI盘前股价翻倍

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet